William Wood
Stock Analyst at B. Riley Securities
(3.46)
# 3,790
Out of 12,268 analysts
47
Total ratings
47.5%
Success rate
9%
Average return
Main Sectors:
Stocks Rated by William Wood
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMUX Immunic | Maintained: Buy | $50 → $27 | $13.05 | +106.90% | 10 | May 22, 2026 | |
| AARD Aardvark Therapeutics | Maintained: Buy | $8 → $7 | $4.54 | +54.19% | 3 | May 15, 2026 | |
| EQ Equillium | Initiated Coverage: Buy | $6 | $2.26 | +165.49% | 1 | Apr 16, 2026 | |
| ALT Altimmune | Maintained: Buy | $13 | $2.90 | +348.28% | 1 | Mar 6, 2026 | |
| PALI Palisade Bio | Initiated Coverage: Buy | $7 | $1.95 | +258.97% | 1 | Jan 9, 2026 | |
| MDGL Madrigal Pharmaceuticals | Maintained: Buy | $560 → $670 | $517.26 | +29.53% | 3 | Dec 11, 2025 | |
| OKYO OKYO Pharma | Initiated Coverage: Buy | $5 | $1.63 | +206.75% | 1 | Dec 8, 2025 | |
| CGTX Cognition Therapeutics | Maintained: Buy | $3 | $1.26 | +138.10% | 1 | Nov 21, 2025 | |
| VERU Veru Inc. | Reiterated: Buy | $50 | $2.35 | n/a | 7 | Feb 11, 2025 | |
| LFMD LifeMD | Maintained: Buy | $12 → $11 | $4.19 | n/a | 10 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $11.44 | n/a | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $4.10 | n/a | 4 | May 2, 2024 |
Immunic
May 22, 2026
Maintained: Buy
Price Target: $50 → $27
Current: $13.05
Upside: +106.90%
Aardvark Therapeutics
May 15, 2026
Maintained: Buy
Price Target: $8 → $7
Current: $4.54
Upside: +54.19%
Equillium
Apr 16, 2026
Initiated Coverage: Buy
Price Target: $6
Current: $2.26
Upside: +165.49%
Altimmune
Mar 6, 2026
Maintained: Buy
Price Target: $13
Current: $2.90
Upside: +348.28%
Palisade Bio
Jan 9, 2026
Initiated Coverage: Buy
Price Target: $7
Current: $1.95
Upside: +258.97%
Madrigal Pharmaceuticals
Dec 11, 2025
Maintained: Buy
Price Target: $560 → $670
Current: $517.26
Upside: +29.53%
OKYO Pharma
Dec 8, 2025
Initiated Coverage: Buy
Price Target: $5
Current: $1.63
Upside: +206.75%
Cognition Therapeutics
Nov 21, 2025
Maintained: Buy
Price Target: $3
Current: $1.26
Upside: +138.10%
Veru Inc.
Feb 11, 2025
Reiterated: Buy
Price Target: $50
Current: $2.35
Upside: n/a
LifeMD
Aug 8, 2024
Maintained: Buy
Price Target: $12 → $11
Current: $4.19
Upside: n/a
May 8, 2024
Reiterated: Buy
Price Target: $10
Current: $11.44
Upside: n/a
May 2, 2024
Maintained: Buy
Price Target: $4
Current: $4.10
Upside: n/a